INSMED INCORPORATED (INSM) Return on equity 2016–2025
INSMED INCORPORATED (INSM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-172.8%FY2025 · since FY2016: -114.1% → -172.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -172.8% | +147.4 pp |
| FY2024 | -320.2% | — |
| FY2022 | -547.5% | -441.6 pp |
| FY2021 | -105.9% | +0.7 pp |
| FY2020 | -106.6% | -9.4 pp |
| FY2019 | -97.2% | +58.5 pp |
| FY2018 | -155.7% | -102.3 pp |
| FY2017 | -53.4% | +60.7 pp |
| FY2016 | -114.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice